S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q2 2022

Avoro Capital Advisors

Period: Q2 2022 Β· Filed: 2022-08-15
View on SEC EDGAR β†—
AUM
$5.06B
Total portfolio value
Positions
40
Reported securities
Top Holding
UTHR
13.8% $699.9M
QoQ Changes
+1 / -4
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-08-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
UTHRUNITED THERAPEUTICS CORP$699.9M13.83%$235.64$555.91+135.9%
13.8%
ARGXARGENX SE$479.5M9.48%$378.88$939.68+148.0%
9.5%
APLSAPELLIS PHARMACEUTICALS INC$443.4M8.76%$45.22β€”
8.8%
HZNPHORIZON THERAPEUTICS PLC$398.8M7.88%β€”β€”
7.9%
MRTXMIRATI THERAPEUTICS INC$372.6M7.36%β€”β€”
7.4%
FOLDAMICUS THERAPEUTICS INC$287.8M5.69%β€”β€”
5.7%
BMRNBIOMARIN PHARMACEUTICAL INC$272.1M5.38%$82.87$58.99-28.8%
5.4%
SGENSEAGEN INC$269.8M5.33%β€”β€”
5.3%
SRPTSAREPTA THERAPEUTICS INC$254.1M5.02%$74.96$19.28-74.3%
5.0%
ASNDASCENDIS PHARMA$211.5M4.18%$92.96$274.50+195.3%
4.2%
ALNYALNYLAM PHARMACEUTICALS INC$198.4M3.92%$145.85$312.78+114.5%
3.9%
XENEXENON PHARMACEUTICALS INC$149.1M2.95%$30.42$60.96+100.4%
3.0%
MDGLMADRIGAL PHARMACEUTICALS INC$109.9M2.17%$71.58$528.10+637.8%
2.2%
IOVAIOVANCE BIOTHERAPEUTICS INC$101.8M2.01%$11.04$4.31-61.0%
2.0%
KURAKURA ONCOLOGY INC$88.0M1.74%$18.33$11.10-39.4%
1.7%
KRYSKRYSTAL BIOTECH INC$70.6M1.39%$65.66$375.07+471.2%
1.4%
BCRXBIOCRYST PHARMACEUTICALS INC$68.8M1.36%$10.58$9.84-7.0%
1.4%
ISEEIVERIC BIO INC$68.5M1.35%β€”β€”
1.4%
XBISPDR SERIES TRUST - S&P BIOTECH$66.8M1.32%$73.80$160.46+117.4%
1.3%
RAREULTRAGENYX PHARMACEUTICAL INC$44.7M0.88%$59.66$33.47-43.9%
0.9%
PMVPPMV PHARMACEUTICALS INC$44.2M0.87%$14.25$1.22-91.4%
0.9%
SNDXSYNDAX PHARMACEUTICALS INC$42.8M0.84%$19.24$21.82+13.4%
0.8%
MRSNMERSANA THERAPEUTICS INC$34.9M0.69%β€”β€”
0.7%
MNKDMANNKIND CORP$34.7M0.69%$3.81$4.52+18.6%
0.7%
GLUEMONTE ROSA THERAPEUTICS INC$32.0M0.63%$9.67$24.21+150.4%
0.6%
DSGNDESIGN THERAPEUTICS INC$31.1M0.61%$14.00$15.64+11.7%
0.6%
CBAYCYMABAY THERAPEUTICS INC$30.4M0.60%β€”β€”
0.6%
KYMRKYMERA THERAPEUTICS INC$24.8M0.49%$19.69$113.51+476.5%
0.5%
WHWKAADI BIOSCIENCES INC$22.5M0.45%$12.32$4.19-66.0%
0.5%
RNAMAVIDITY BIOSCIENCES INC$18.9M0.37%β€”β€”
0.4%

Quarter-on-Quarter Activity

Q2 2022 vs. Q1 2022

New Positions (1)

TickerIssuerNotional
RLAYRELAY THERAPEUTICS INC$6.7M

Exited Positions (4)

TickerIssuerNotional
ACADACADIA PHARMACEUTICALS INC$55.1M
PRAXPRAXIS PRECISION MEDICINES INC$21.9M
AVDLXXXXAVADEL PHARMACEUTICALS PLC$11.4M
ADVMADVERUM BIOTECHNOLOGIES INC$9.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
BCRXBIOCRYST PHARMACEUTICALS INC$38.3M+246.7%-7.0%
RAREULTRAGENYX PHARMACEUTICAL INC$28.0M+226.1%-43.9%
KYMRKYMERA THERAPEUTICS INC$-9.7M+54.3%+476.5%
PMVPPMV PHARMACEUTICALS INC$-1.6M+40.9%-91.4%
FOLDAMICUS THERAPEUTICS INC$93.7M+30.7%
SGENSEAGEN INC$80.4M+16.0%
MRSNMERSANA THERAPEUTICS INC$7.8M+11.0%
BMRNBIOMARIN PHARMACEUTICAL INC$38.1M+8.2%-28.8%

Trimmed (5)

TickerIssuerNotionalShares Ξ”Since Filing
XBISPDR SERIES TRUST - S&P BIOTECH$-207.3M-70.5%+117.4%
HZNPHORIZON THERAPEUTICS PLC$-285.1M-23.1%
UTHRUNITED THERAPEUTICS CORP$156.2M-2.0%+135.9%
ISEEIVERIC BIO INC$-53.5M-1.8%
XENEXENON PHARMACEUTICALS INC$-3.3M-1.7%+100.4%
← Back to Hedge Funds